Biongevity Clinic opens in Dubai

UAE — Biongevity, Dubai’s first clinic dedicated to longevity, has been launched, marking a major advancement in the UAE’s healthcare landscape.

Specializing in precision medicine, the clinic offers personalised healthcare solutions through cutting-edge genomics, AI-driven insights, and data analysis, all aimed at optimizing both healthspan and quality of life.

Biongevity employs advanced technologies such as PanomiQ and BioELR, which allow for comprehensive, data-driven health assessments and tailored treatment plans.

By integrating sophisticated AI algorithms with multi-omics data, the clinic’s approach signifies a notable leap forward in both precision medicine and longevity science.

Additionally, the Virtual Hypertension Clinic enables patients to receive individualized care remotely, while the Longevity Plus Supplements provide scientifically backed nutrition to support long-term health and vitality.

A key feature of the clinic is its multidisciplinary team, which includes experts from various medical fields working collaboratively to address every aspect of a patient’s health.

General practice, internal medicine, cardiology, gastroenterology, and dermatology are among the specialties offered, each designed to provide bespoke healthcare solutions.

Through a combination of state-of-the-art diagnostics, genetic analyses, and AI-powered medical insights, Biongevity aims to set a new benchmark in healthcare standards.

The clinic’s highly anticipated launch event attracted leaders from the healthcare, technology, and wellness sectors.

Dr. Anmol S. Kapoor, MD FRCPC, a cardiologist and the founder of Biongevity, spoke at the event, outlining the clinic’s mission to transform healthcare by moving beyond traditional disease management.

He emphasized the clinic’s focus on preventive care, with a goal to offer healthcare solutions that align with each individual’s genetic profile, lifestyle, and microbiome.

As demand for longevity and life-extension treatments grows globally, driven by increasing interest in health, wellness, and anti-aging solutions, Biongevity is strategically positioned to meet this rising need.

Medical advancements in biotechnology and regenerative medicine are propelling people toward extending their healthy years and improving their quality of life.

The global market for anti-aging products and services, which was valued at US$60.42 billion in 2021, is projected to nearly double by 2030, reaching US$120.3 billion with a compound annual growth rate of 7.2%.

The aging population, particularly in Europe, the U.S., and parts of Asia, is a key driver of this demand, with increased interest in treatments that slow aging and mitigate age-related diseases.

High net-worth individuals are playing a significant role as early adopters of these treatments, with many spending between US$15,000 and US$100,000 annually on personalized therapies and interventions.

 In the U.S. and the Middle East, this trend is especially pronounced. Additionally, the growing emphasis on holistic health and preventive care is pushing longevity medications into mainstream healthcare, as part of a broader wellness strategy to extend life expectancy and enhance quality of life.

Biongevity’s launch aligns with the UAE’s strategic focus on advancing genomics and preventive healthcare, supported by initiatives like the Emirati Genome Programme.

This program, which has already collected over 600,000 DNA samples, aims to generate a comprehensive genetic reference for the Emirati population.

The insights from this initiative are expected to drive the development of personalized healthcare and new treatments for rare genetic disorders.

Dr. Kapoor highlighted Biongevity’s commitment to supporting the UAE’s vision of becoming a global leader in genomics and longevity science.

Following the successful launch in Dubai, Biongevity plans to expand internationally, with clinics set to open in major cities across the GCC, London, Silicon Valley, and Toronto by 2026.

This expansion will further its vision of democratizing access to advanced healthcare technologies worldwide. 

Sign up to receive our email newsletters with the latest news updates and  insights from Africa and the World HERE